Filing Details
- Accession Number:
- 0001209191-23-056071
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-11-20 16:31:38
- Reporting Period:
- 2023-11-16
- Accepted Time:
- 2023-11-20 16:31:38
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1850906 | Singular Genomics Systems Inc. | OMIC | Laboratory Analytical Instruments (3826) | 812948451 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1859701 | Andrew Spaventa | 3010 Science Park Road San Diego CA 92121 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-11-16 | 43,468 | $0.41 | 3,986,206 | No | 4 | P | Indirect | By The Andrew K. Spaventa Living Trust dated April 9, 2014 |
| Common Stock | Acquisiton | 2023-11-17 | 75,000 | $0.42 | 4,061,206 | No | 4 | P | Indirect | By The Andrew K. Spaventa Living Trust dated April 9, 2014 |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | By The Andrew K. Spaventa Living Trust dated April 9, 2014 |
| No | 4 | P | Indirect | By The Andrew K. Spaventa Living Trust dated April 9, 2014 |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 9,766 | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.3770 to $0.4200, inclusive. The reporting person undertakes to provide to Singular Genomics Systems, Inc., any security holder of Singular Genomics Systems, Inc., or the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.4200 to $0.4456, inclusive. The reporting person undertakes to provide to Singular Genomics Systems, Inc., any security holder of Singular Genomics Systems, Inc., or the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Billionaire Hedge Funds
